AIM
PTCT icon

Assured Investment Management’s PTC Therapeutics PTCT Stock Holding History

Assured Investment Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-7,404
Closed -$279K – 647
2019
Q1 		$279K Buy
+7,404
New +$249K ﹤0.01% 723
2018
Q4 		– Sell
-4,189
Closed -$197K – 1286
2018
Q3 		$197K Sell
4,189
-22,213
-84% -$919K ﹤0.01% 969
2018
Q2 		$891K Buy
26,402
+5,355
+25% +$167K 0.02% 605
2018
Q1 		$570K Buy
+21,047
New +$533K 0.01% 724

Other funds holding PTCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Assured Investment Management's PTCT Position: Q2 2019 in Review

Assured Investment Management sold out of PTC Therapeutics (PTCT) in Q2 2019, closing a stake of 7,404 shares — an estimated $279K sold.

Assured Investment Management first reported a position in PTCT in Q1 2018 and held it in 4 quarters. The position peaked at $891K in Q2 2018. 176 funds tracked by Wall St. Rank hold PTCT as of Q2 2019.

  • Assured Investment Management reported no remaining PTC Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 7,404 PTC Therapeutics shares in Q2 2019, an estimated $279K.
  • Assured Investment Management first reported a position in PTC Therapeutics in Q1 2018 and held it in 4 quarters.
  • Assured Investment Management's PTC Therapeutics position peaked at $891K in Q2 2018.
  • 176 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.